• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Zydus`s Generic Propafenone Hydrochloride Receives Approval In US

    21 Apr 2021 //

    FDA

    Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules

    30 Jun 2020 //

    PRNEWSWIRE

    Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules

    30 Jun 2020 //

    PRESS RELEASE

    Upsher Smith`s Generic Propafenone Hydrochloride Approved in US

    30 Jun 2020 //

    FDA

    Vitruvias, Sinotherapeutics launch approved version of Propafenone ER U.S.

    11 Mar 2019 //

    BIOSPECTRUMASIA

    Sinotherapeutics` Generic Propafenone Hydrochloride Receives Approval in US

    07 Jan 2019 //

    FDA

    Indicus Pharma’s Generic Propafenone Hydrochloride Receives Approval in the US

    05 Jul 2018 //

    FDA

    Glenmark Pharm’s Generic Propafenone Hydrochloride Receives Approval In US

    13 Sep 2017 //

    FDA

    Enforcement Report - Week of September 13, 2017

    13 Sep 2017 //

    FDA

    Glenmark gets USFDA approval for Rythmol SR generic

    11 Sep 2017 //

    ECONOMIC TIMES

    Mylan Launches Generic Rythmol® Sustained-Release Capsules

    02 Jun 2016 //

    PR NEWSWIRE

    Orion Corp Orion`s Generic Propafenone HCl approved in US as antiarrhythmic drug

    11 May 2016 //

    FDA

    Mylan Pharms inc`s Generic Propafenone Hydrochloride approved in US as an Anti-arrhythmic Drug

    29 Apr 2016 //

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.